Cyproterone Acetate and Ethinylestradiol Tablets
Formulated to treat androgen-dependent skin conditions; indicated to alleviate symptoms of severe acne in women.
Strengths: 2/0.035mg
Where to Check Availability
Medicine details
- Alternative names
Dianette; Diane 35
- Therapeutic class
Antiandrogen; oestrogen
- Pharmacological class
Antiandrogen; oestrogen
- Contraindications
history of venous thromboembolism; pregnancy; breast cancer
- Precautions and warnings
increased risk of venous thromboembolism; regular blood pressure monitoring
- Minor side effects
nausea; abdominal pain; headache; weight change
- Moderate side effects
breast tenderness; mood swings
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Bayer
- Onset Time
3–4 months
- Duration
daily cycle
- Storage instructions
Store below 25°C.
- Drug interactions
rifampicin; carbamazepine; st. john's wort
- Age restrictions
Not for pre-pubescent use.
- Pregnancy and breastfeeding
Pregnancy: must not be used. Breastfeeding: not recommended.
Serious side effects
venous thromboembolism — requires immediate medical attention; stroke — requires immediate medical attention
Patient summary
Formulated to treat androgen-dependent skin conditions; indicated to alleviate symptoms of severe acne in women.
Mechanism of action
A combination hormonal product. Cyproterone acts as an anti-androgen by blocking androgen receptors, reducing sebum production. Ethinylestradiol enhances this effect by increasing sex hormone-binding globulin, decreasing free androgen levels.
Cyproterone Acetate and Ethinylestradiol Tablets
Formulated to treat androgen-dependent skin conditions; indicated to alleviate symptoms of severe acne in women.
Editorial Notes
- Active ingredient(s): Cyproterone, Ethinylestradiol
- Listed indication(s): Severe Acne, Hirsutism, Androgenetic Alopecia
Available option
- 105 tablets - 2/0.035 mg1363-2-0-035-mg-16384